Leadership
Leadership
I am committed to advancing the field of child and adolescent psychiatry through active service and leadership at the national and international level. Across my appointed roles in professional organizations, institutional leadership, and editorial work, I aim to strengthen education and training standards, promote evidence-based practice, and expand access to mental health care for children, adolescents, and families. Below is a summary of my current and recent leadership responsibilities.
American Academy of Child & Adolescent Psychiatry (AACAP)
Clinical Essentials Committee, Appointed Member (2024–2026)
Psychopharmacology & Neurotherapeutics Committee, Appointed Member (2022–2026)
American Professional Society of ADHD and Related Disorders (APSARD)
Board of Directors, Member (2023–2026)
American Board of Psychiatry and Neurology (ABPN)
Child & Adolescent Psychiatry Certification Committee, Member (2025–2029)
American Society of Clinical Psychopharmacology (ASCP)
Program Committee, Member (2022–2025)
International Association for Child & Adolescent Psychiatry and Allied Professions (IACAPAP)
Pediatric Psychopharmacology Special Interest Group, Founding Member (2025–present)
Penn State College of Medicine & Penn State Children's Hospital
Associate Vice Chair, Faculty Development, Department of Psychiatry and Behavioral Health (2022–present)
Associate Chief, Child and Adolescent Psychiatry (2022–present)
Co-Director, Child Psychiatry Consultation and Liaison Services (2021–present)
Zero Suicide Initiative, Training Program Lead (2023–2025)
Penn State University
Faculty Senate Elected Member (2022–2030)
Editorial Board
Journal of Attention Disorders (2024–present)
JAACAP Open (2023–present)
Peer Reviewer
25+ journals including the Journal of the American Academy of Child & Adolescent Psychiatry, American Journal of Psychiatry, Nature Medicine, and Pediatrics